Mark Schenkel is a partner in Sullivan & Cromwell’s Intellectual Property and Technology Transactions Group. Mr. Schenkel’s practice is focused on strategic and commercial transactions involving the development, licensing and transfer of intellectual property, software, algorithms, data, content, pharmaceuticals and biopharmaceuticals, medical devices and other technologies. His practice also includes technology-intensive mergers, acquisitions, divestitures, joint ventures and collaborations, as well as IP litigation settlement agreements.
In addition to his transactional work, Mr. Schenkel regularly counsels a broad range of clients on matters regarding IP; artificial intelligence, open source and other technologies; and privacy and cybersecurity.
Mr. Schenkel has been described as a leader with “broad horizons and excellent strategic judgement” (IAM Patent 1000). He is ranked by Chambers USA, selected as a 2024 Dealmaker of the Year by The American Lawyer, and is regularly recognized by other leading industry publications such as Intellectual Asset Management (IAM) and The Financial Times.